SCHEMBL7597702

SCHEMBL7597702

CCC(Cc1ccccc1)=C(c1ccccc1)c1ccc(NCCCOC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.43
ABCB11 O95342 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2B P18089 1/20 0.41
OPRD1 P41143 1/20 0.41
SCN5A Q14524 1/20 0.41
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 4/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
KCNH3 Q9ULD8 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP19A1 P11511 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HDAC3 O15379 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7600851 1.00 ESR1 (0.43) ESR1ABCB11CYP3A4ADRA2BOPRD1
SCHEMBL7599310 0.93 ESR1 (0.44) ESR1ABCB11CYP3A4ADRA2BOPRD1
SCHEMBL7598327 0.93 ESR1 (0.44) ESR1ABCB11CYP3A4ADRA2BOPRD1
SCHEMBL7596104 0.89 SMN1; SMN2 (0.43) ESR1TDP1ALDH1A1LMNAKDM4E
SCHEMBL7598596 0.89 SMN1; SMN2 (0.43) ESR1TDP1ALDH1A1LMNAKDM4E
SCHEMBL7602285 0.88 ESR1 (0.41) ESR1ABCB11CYP3A4ADRA2BOPRD1
SCHEMBL7602281 0.88 ESR1 (0.41) ESR1ABCB11CYP3A4ADRA2BOPRD1
SCHEMBL7603604 0.86 ESR1 (0.41) ESR1ALDH1A1KCNH3CA1CA2
SCHEMBL7603602 0.86 ESR1 (0.41) ESR1ALDH1A1KCNH3CA1CA2
SCHEMBL7600075 0.86 ESR1 (0.47) ESR1ALDH1A1KCNH3SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020161007-A1 Non-steroidal modulators of estrogen receptors PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161007-A1 Non-steroidal modulators of estrogen receptors ESRRB, ESR2, ESRRG ESR1 6/4885ABCB11 3158/4885CYP3A4 1527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.